Entity
  • SciRhom

    Created in 2016
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups
  • Social networks

    831
  • Activities

  • Technologies

  • Entity types

  • Location

    Innovations- und Gründerzentrum Biotechnologie (IZB), Am Klopferspitz 19, 82152 Planegg, Germany

    Planegg

    Germany

  • Employees

    Scale: 2-10

    Estimated: 16

  • Engaged corporates

    3
    2 2
  • Added in Motherbase

    3 months, 2 weeks ago
Description
  • Value proposition

    Targeting iRhom2 for better treatment of autoimmune diseases

    SciRhom GmbH, based in IZB Martinsried, Germany, is a biotech start-up company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening diseases. Founded in late 2016, we develop first-in-class antibodies against iRhom2, a key modulator of several crucial pro-inflammatory signalling pathways, including TNF-alpha signalling. Following the preclinical and early clinical development of these monoclonal antibodies, we are aiming to provide superior treatment options to currently existing inhibitors of TNF-alpha signaling. SciRhom is poised to transform the lives of patients with autoimmune diseases.

    drug development, targeted therapy, and drug discovery

Corporate interactions BETA
Corporate TypeTweets Articles
Eurazeo
Eurazeo
Finance, Financial Services
Eurazeo
Finance, Financial Services
Other

9 Oct 2024


HTGF | High-Tech Gründerfonds
HTGF | High-Tech Gründerfonds
Venture Capital and Private Equity Principals
HTGF | High-Tech Gründerfonds
Venture Capital and Private Equity Principals
Other

14 Jul 2024


Kurma Partners
Kurma Partners
Startup accelerator & VC, Venture Capital and Private Equity Principals
Kurma Partners
Startup accelerator & VC, Venture Capital and Private Equity Principals
Other

9 Oct 2024


Similar entities
Loading...
Loading...
Social network dynamics